Literature DB >> 24712333

Should we reconsider lung transplantation through uncontrolled donation after circulatory death?

Y Suzuki1, J L Tiwari, J Lee, J M Diamond, N P Blumenthal, K Carney, C Borders, J Strain, G W Alburger, D Jackson, J Timar, J Berg, R D Hasz, E Cantu.   

Abstract

Lung transplantation through controlled donation after circulatory death (cDCD) has slowly gained universal acceptance with reports of equivalent outcomes to those through donation after brain death. In contrast, uncontrolled DCD (uDCD) lung use is controversial and requires ethical, legal and medical complexities to be addressed in a limited time. Consequently, uDCD lung use has not previously been reported in the United States. Despite these potential barriers, we present a case of a patient with multiple gunshot wounds to the head and the body who was unsuccessfully resuscitated and ultimately became an uDCD donor. A cytomegalovirus positive recipient who had previously consented for CDC high-risk, DCD and participation in the NOVEL trial was transplanted from this uDCD donor, following 3 h of ex vivo lung perfusion. The postoperative course was uneventful, and the recipient was discharged home on day 9. While this case represents a "best-case scenario," it illustrates a method for potential expansion of the lung allograft pool through uDCD after unsuccessful resuscitation in hospitalized patients. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Cardiac arrest; cardiac death donors; ex vivo lung perfusion; intensive care; lung transplantation; resuscitation

Mesh:

Year:  2014        PMID: 24712333      PMCID: PMC4273571          DOI: 10.1111/ajt.12633

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

1.  Brain arrest to neurological determination of death to organ utilization: the evolution of hospital-based organ donation strategies in Canada.

Authors:  Sam D Shemie
Journal:  Can J Anaesth       Date:  2006-08       Impact factor: 5.063

2.  Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes.

Authors:  Luis F Angel; Deborah J Levine; Marcos I Restrepo; Scott Johnson; Edward Sako; Andrea Carpenter; John Calhoon; John E Cornell; Sandra G Adams; Gary B Chisholm; Joe Nespral; Ann Roberson; Stephanie M Levine
Journal:  Am J Respir Crit Care Med       Date:  2006-06-23       Impact factor: 21.405

3.  Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours.

Authors:  S Steen; R Ingemansson; A Budrikis; R Bolys; R Roscher; T Sjöberg
Journal:  Ann Thorac Surg       Date:  1997-02       Impact factor: 4.330

4.  Extended preservation of ischemic pulmonary graft by postmortem alveolar expansion.

Authors:  D E Van Raemdonck; N C Jannis; F R Rega; P R De Leyn; W J Flameng; T E Lerut
Journal:  Ann Thorac Surg       Date:  1997-09       Impact factor: 4.330

5.  Ex vivo evaluation of human lungs for transplant suitability.

Authors:  Thomas M Egan; John A Haithcock; William A Nicotra; Giovanna Koukoulis; Hidetoshi Inokawa; Mayura Sevala; Paul L Molina; William K Funkhouser; Burton J Mattice
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

6.  Circulatory death determination in uncontrolled organ donors: a panel viewpoint.

Authors:  James L Bernat; Thomas P Bleck; Sandralee A Blosser; Susan L Bratton; Alexander M Capron; Danielle Cornell; Michael A DeVita; Gerard J Fulda; Alexandra K Glazier; Cynthia J Gries; Mudit Mathur; Thomas A Nakagawa; Sam D Shemie
Journal:  Ann Emerg Med       Date:  2013-06-21       Impact factor: 5.721

7.  Successful extrarenal transplantation from non-heart-beating donors.

Authors:  A M D'Alessandro; R M Hoffmann; S J Knechtle; D E Eckhoff; R B Love; M Kalayoglu; H W Sollinger; F O Belzer
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

8.  Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo.

Authors:  Stig Steen; Qiuming Liao; Per N Wierup; Ramunas Bolys; Leif Pierre; Trygve Sjöberg
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

9.  Left lower lobe transplantation during a bilateral single lung transplantation (pulmonary lobe transplantation).

Authors:  A Bisson; P Bonnette; A Perruchoud; M Leroy; A Colchen; L Raffin; P Loirat
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

10.  A strategy to increase the donor pool: use of cadaver lungs for transplantation.

Authors:  T M Egan; C J Lambert; R Reddick; K S Ulicny; B A Keagy; B R Wilcox
Journal:  Ann Thorac Surg       Date:  1991-11       Impact factor: 4.330

View more
  5 in total

1.  Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) as a Source of Lungs for Transplant.

Authors:  T M Egan; J J Requard
Journal:  Am J Transplant       Date:  2015-04-14       Impact factor: 8.086

Review 2.  History of lung transplantation.

Authors:  Federico Venuta; Dirk Van Raemdonck
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  The unique moral permissibility of uncontrolled lung donation after circulatory death.

Authors:  Brendan Parent; Arthur Caplan; Luis Angel; Zachary Kon; Nancy Dubler; Lewis Goldfrank; Jacob Lindner; Stephen P Wall
Journal:  Am J Transplant       Date:  2019-10-18       Impact factor: 8.086

Review 4.  Ex-vivo lung perfusion therapies: do they add value to organ donation?

Authors:  Amit Lyengar; Alexis Schiazza; Edward Cantu
Journal:  Curr Opin Organ Transplant       Date:  2022-06-01       Impact factor: 2.269

5.  Successful Transplantation of Lungs From an Uncontrolled Donor After Circulatory Death Preserved In Situ by Alveolar Recruitment Maneuvers and Assessed by Ex Vivo Lung Perfusion.

Authors:  F Valenza; G Citerio; A Palleschi; A Vargiolu; B Safaee Fakhr; A Confalonieri; M Nosotti; S Gatti; S Ravasi; S Vesconi; A Pesenti; F Blasi; L Santambrogio; L Gattinoni
Journal:  Am J Transplant       Date:  2016-01-30       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.